Announce Date | 03/21/2024 |
EPS Normalized Actual | $2.21 (Miss by $-0.13) |
EPS GAAP Actual | $2.21 (Miss by $-0.13) |
Revenue Actual | $1.46773B |
Revenue Surprise | Beat by $1467.73M |
Announce Date | 04/28/2024 (Pre-Market) |
EPS Normalized Estimate | $1.38634 |
EPS GAAP Estimate | $1.38634 |
Revenue Estimate | $1.41175694B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2028 | 9.99 | 5.44 | 9.71333 | 10.42226 | 2 |
Jan 2028 | 11.68 | 4.66 | 11.20357 | 12.17789 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (Apr 2022) | 1.73 | 1.73 | 1.46773B | -7.67% | 1467.73M |
FQ1 2022 (Jan 2022) | 1.61 | 1.61 | 1.80847B | 11.67% | 1808.47M |
FQ4 2021 (Oct 2021) | 1.77 | 1.77 | 1.5928B | 15.3% | 1592.8M |
FQ3 2021 (Jul 2021) | 2.06 | 2.06 | 1.79153B | 10.33% | 1791.53M |
FQ2 2021 (May 2021) | 1.93 | 1.93 | 1.58033B | 28.1% | 1580.33M |
FQ1 2021 (Jan 2021) | 1.01 | 1.01 | 1.59744B | 14.21% | 1597.44M |
FQ4 2020 (Oct 2020) | 0.78 | 0.78 | 1.34908B | 15.11% | 1349.08M |
FQ3 2020 (Jul 2020) | 1.65039 | 1.65039 | 1.60642B | 22.97% | 1606.42M |
FQ4 Announce Date
04/28/2024 (Pre-Market)
Consensus EPS Estimates
1.38634
Consensus Revenue Estimates
1.41175694B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Nov 2026) | 1.9898 | -- | 1.9404 | 2.05869 | 4 |
FQ3 2026 (Aug 2026) | 2.9291 | -- | 2.85637 | 3.03051 | 4 |
FQ2 2026 (May 2026) | 1.7118 | -- | 1.6693 | 1.77107 | 8 |
FQ1 2026 (Feb 2026) | 2.16848 | -- | 2.1138 | 2.29293 | 4 |
FQ4 2025 (Nov 2025) | 1.56102 | -- | 1.52166 | 1.65061 | 5 |
FQ3 2025 (Aug 2025) | 2.35311 | -- | 2.29378 | 2.48816 | 5 |
FQ2 2025 (May 2025) | 1.36369 | -- | 1.3293 | 1.44195 | 5 |
FQ1 2025 (Feb 2025) | 2.3406 | -- | 2.28158 | 2.47493 | 5 |
FQ4 2024 (Oct 2024) | 1.58128 | -- | 1.50569 | 1.67294 | 6 |
FQ3 2024 (Jul 2024) | 2.27552 | -- | 2.16674 | 2.40743 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Nov 2026) | 1.77B | -- | 1.74B | 1.82B | 5 |
FQ3 2026 (Aug 2026) | 1.96B | -- | 1.92B | 2.01B | 5 |
FQ2 2026 (May 2026) | 1.66B | -- | 1.62B | 1.7B | 9 |
FQ1 2026 (Feb 2026) | 1.93B | -- | 1.89B | 2.01B | 6 |
FQ4 2025 (Nov 2025) | 1.57B | -- | 1.54B | 1.64B | 4 |
FQ3 2025 (Aug 2025) | 1.73B | -- | 1.7B | 1.81B | 4 |
FQ2 2025 (May 2025) | 1.47B | -- | 1.44B | 1.54B | 7 |
FQ1 2025 (Feb 2025) | 1.83B | -- | 1.79B | 1.91B | 4 |
FQ4 2024 (Oct 2024) | 1.49B | -- | 1.43B | 1.55B | 5 |
FQ3 2024 (Jul 2024) | 1.65B | -- | 1.59B | 1.72B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | 1.73 | 1.73 | 100% | |
FQ1 2022 (Jan 2022) | 1.61 | 1.61 | 100% | |
FQ4 2021 (Oct 2021) | 1.77 | 1.77 | 100% | |
FQ3 2021 (Jul 2021) | 2.06 | 2.06 | 100% | |
FQ2 2021 (May 2021) | 1.93 | 1.93 | 100% | |
FQ1 2021 (Jan 2021) | 1.01 | 1.01 | 100% | |
FQ4 2020 (Oct 2020) | 0.78 | 0.78 | 100% | |
FQ3 2020 (Jul 2020) | 1.65039 | 1.65039 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | $0B | $1.47B | $1467.73M | 100% |
FQ1 2022 (Jan 2022) | $0B | $1.81B | $1808.47M | 100% |
FQ4 2021 (Oct 2021) | $0B | $1.59B | $1592.8M | 100% |
FQ3 2021 (Jul 2021) | $0B | $1.79B | $1791.53M | 100% |
FQ2 2021 (May 2021) | $0B | $1.58B | $1580.33M | 100% |
FQ1 2021 (Jan 2021) | $0B | $1.6B | $1597.44M | 100% |
FQ4 2020 (Oct 2020) | $0B | $1.35B | $1349.08M | 100% |
FQ3 2020 (Jul 2020) | $0B | $1.61B | $1606.42M | 100% |